Modifiable patient factors are associated with reverse vein graft occlusion in the era of duplex scan surveillance

Mary E. Giswold, Gregory Landry, Gary J. Sexton, Richard A. Yeager, James Edwards, Lloyd M. Taylor, Gregory (Greg) Moneta

    Research output: Contribution to journalArticle

    23 Citations (Scopus)

    Abstract

    Objective: Modifiable patient factors that contribute to graft occlusion may be addressed after surgery. To determine risk factors associated with reverse vein graft (RVG) occlusion, we examined the characteristics and duplex scan surveillance (DS) patterns of patients with RVGs. Methods: Patients treated with RVG from January 1996 through December 2000 were identified from a prospective registry. The study population consisted of all patients with RVGs performed during the study period with grafts that subsequently occluded. Patients whose grafts remained patent served as age-matched and gender-matched control subjects. The prescribed DS regimen was every 3 months for the first postoperative year and every 6 months thereafter. Early DS failure was defined as having no DS within the first 3 months. Cox proportional hazards analysis was used to compare the two groups. Hazard ratios were calculated. Results: During the study period, 674 patients underwent RVG. Fifty-five patients with occluded RVGs were compared with 118 with patent RVGs. The follow-up period for occluded grafts was 13.40 ± 12.59 months and for patent grafts was 32.40 ± 15.61 months. Dialysis therapy, a known hypercoagulable state, continued smoking, and DS failure were independent factors associated with RVG occlusion. The hazards ratio for dialysis was 6.45 (95% CI, 3.07 to 13.51; P <.001), for current smoking was 4.72 (95% CI, 2.5 to 8.85; P <.001), for hypercoagulable state was 2.99 (95% CI, 1.47 to 6.10; P = .003), and for early DS failure was 2.43 (95% CI, 1.29 to 4.59; P = .006). Conclusion: Continued smoking and failure to undergo DS within the first three postoperative months are modifiable factors associated with RVG occlusion. Smoking cessation and graft surveillance must be stressed to optimize patency of infrainguinal RVGs.

    Original languageEnglish (US)
    Pages (from-to)47-53
    Number of pages7
    JournalJournal of Vascular Surgery
    Volume37
    Issue number1
    DOIs
    StatePublished - Jan 1 2003

    Fingerprint

    Veins
    Transplants
    Smoking
    Dialysis
    Smoking Cessation
    Registries

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Surgery

    Cite this

    Modifiable patient factors are associated with reverse vein graft occlusion in the era of duplex scan surveillance. / Giswold, Mary E.; Landry, Gregory; Sexton, Gary J.; Yeager, Richard A.; Edwards, James; Taylor, Lloyd M.; Moneta, Gregory (Greg).

    In: Journal of Vascular Surgery, Vol. 37, No. 1, 01.01.2003, p. 47-53.

    Research output: Contribution to journalArticle

    @article{274993013810416bac025a88094a1de8,
    title = "Modifiable patient factors are associated with reverse vein graft occlusion in the era of duplex scan surveillance",
    abstract = "Objective: Modifiable patient factors that contribute to graft occlusion may be addressed after surgery. To determine risk factors associated with reverse vein graft (RVG) occlusion, we examined the characteristics and duplex scan surveillance (DS) patterns of patients with RVGs. Methods: Patients treated with RVG from January 1996 through December 2000 were identified from a prospective registry. The study population consisted of all patients with RVGs performed during the study period with grafts that subsequently occluded. Patients whose grafts remained patent served as age-matched and gender-matched control subjects. The prescribed DS regimen was every 3 months for the first postoperative year and every 6 months thereafter. Early DS failure was defined as having no DS within the first 3 months. Cox proportional hazards analysis was used to compare the two groups. Hazard ratios were calculated. Results: During the study period, 674 patients underwent RVG. Fifty-five patients with occluded RVGs were compared with 118 with patent RVGs. The follow-up period for occluded grafts was 13.40 ± 12.59 months and for patent grafts was 32.40 ± 15.61 months. Dialysis therapy, a known hypercoagulable state, continued smoking, and DS failure were independent factors associated with RVG occlusion. The hazards ratio for dialysis was 6.45 (95{\%} CI, 3.07 to 13.51; P <.001), for current smoking was 4.72 (95{\%} CI, 2.5 to 8.85; P <.001), for hypercoagulable state was 2.99 (95{\%} CI, 1.47 to 6.10; P = .003), and for early DS failure was 2.43 (95{\%} CI, 1.29 to 4.59; P = .006). Conclusion: Continued smoking and failure to undergo DS within the first three postoperative months are modifiable factors associated with RVG occlusion. Smoking cessation and graft surveillance must be stressed to optimize patency of infrainguinal RVGs.",
    author = "Giswold, {Mary E.} and Gregory Landry and Sexton, {Gary J.} and Yeager, {Richard A.} and James Edwards and Taylor, {Lloyd M.} and Moneta, {Gregory (Greg)}",
    year = "2003",
    month = "1",
    day = "1",
    doi = "10.1067/mva.2003.4",
    language = "English (US)",
    volume = "37",
    pages = "47--53",
    journal = "Journal of Vascular Surgery",
    issn = "0741-5214",
    publisher = "Mosby Inc.",
    number = "1",

    }

    TY - JOUR

    T1 - Modifiable patient factors are associated with reverse vein graft occlusion in the era of duplex scan surveillance

    AU - Giswold, Mary E.

    AU - Landry, Gregory

    AU - Sexton, Gary J.

    AU - Yeager, Richard A.

    AU - Edwards, James

    AU - Taylor, Lloyd M.

    AU - Moneta, Gregory (Greg)

    PY - 2003/1/1

    Y1 - 2003/1/1

    N2 - Objective: Modifiable patient factors that contribute to graft occlusion may be addressed after surgery. To determine risk factors associated with reverse vein graft (RVG) occlusion, we examined the characteristics and duplex scan surveillance (DS) patterns of patients with RVGs. Methods: Patients treated with RVG from January 1996 through December 2000 were identified from a prospective registry. The study population consisted of all patients with RVGs performed during the study period with grafts that subsequently occluded. Patients whose grafts remained patent served as age-matched and gender-matched control subjects. The prescribed DS regimen was every 3 months for the first postoperative year and every 6 months thereafter. Early DS failure was defined as having no DS within the first 3 months. Cox proportional hazards analysis was used to compare the two groups. Hazard ratios were calculated. Results: During the study period, 674 patients underwent RVG. Fifty-five patients with occluded RVGs were compared with 118 with patent RVGs. The follow-up period for occluded grafts was 13.40 ± 12.59 months and for patent grafts was 32.40 ± 15.61 months. Dialysis therapy, a known hypercoagulable state, continued smoking, and DS failure were independent factors associated with RVG occlusion. The hazards ratio for dialysis was 6.45 (95% CI, 3.07 to 13.51; P <.001), for current smoking was 4.72 (95% CI, 2.5 to 8.85; P <.001), for hypercoagulable state was 2.99 (95% CI, 1.47 to 6.10; P = .003), and for early DS failure was 2.43 (95% CI, 1.29 to 4.59; P = .006). Conclusion: Continued smoking and failure to undergo DS within the first three postoperative months are modifiable factors associated with RVG occlusion. Smoking cessation and graft surveillance must be stressed to optimize patency of infrainguinal RVGs.

    AB - Objective: Modifiable patient factors that contribute to graft occlusion may be addressed after surgery. To determine risk factors associated with reverse vein graft (RVG) occlusion, we examined the characteristics and duplex scan surveillance (DS) patterns of patients with RVGs. Methods: Patients treated with RVG from January 1996 through December 2000 were identified from a prospective registry. The study population consisted of all patients with RVGs performed during the study period with grafts that subsequently occluded. Patients whose grafts remained patent served as age-matched and gender-matched control subjects. The prescribed DS regimen was every 3 months for the first postoperative year and every 6 months thereafter. Early DS failure was defined as having no DS within the first 3 months. Cox proportional hazards analysis was used to compare the two groups. Hazard ratios were calculated. Results: During the study period, 674 patients underwent RVG. Fifty-five patients with occluded RVGs were compared with 118 with patent RVGs. The follow-up period for occluded grafts was 13.40 ± 12.59 months and for patent grafts was 32.40 ± 15.61 months. Dialysis therapy, a known hypercoagulable state, continued smoking, and DS failure were independent factors associated with RVG occlusion. The hazards ratio for dialysis was 6.45 (95% CI, 3.07 to 13.51; P <.001), for current smoking was 4.72 (95% CI, 2.5 to 8.85; P <.001), for hypercoagulable state was 2.99 (95% CI, 1.47 to 6.10; P = .003), and for early DS failure was 2.43 (95% CI, 1.29 to 4.59; P = .006). Conclusion: Continued smoking and failure to undergo DS within the first three postoperative months are modifiable factors associated with RVG occlusion. Smoking cessation and graft surveillance must be stressed to optimize patency of infrainguinal RVGs.

    UR - http://www.scopus.com/inward/record.url?scp=0037282990&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0037282990&partnerID=8YFLogxK

    U2 - 10.1067/mva.2003.4

    DO - 10.1067/mva.2003.4

    M3 - Article

    C2 - 12514577

    AN - SCOPUS:0037282990

    VL - 37

    SP - 47

    EP - 53

    JO - Journal of Vascular Surgery

    JF - Journal of Vascular Surgery

    SN - 0741-5214

    IS - 1

    ER -